<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Luo Y</submitter><funding>Guangdong Provincial Department of Science and Technology</funding><funding>National Natural Science Foundation of China</funding><funding>the Deng Feng Project of First People's Hospital of Foshan</funding><funding>the Deng Feng Project of First People’s Hospital of Foshan</funding><pagination>13377</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12008296</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Caerin peptides exhibit a dual role in cancer treatment by directly killing cancer cells and modulating the tumour microenvironment to enhance anti-tumour immunity. This study investigates the mechanisms underlying caerin 1.1/1.9-induced acute cell death in epithelial cancer cells and explores their therapeutic potential. HeLa, A549, and Huh-7 cancer cell lines were treated with caerin 1.1/1.9 peptides. Morphological observations, flow cytometry, lactate dehydrogenase (LDH) release, and IL-18 secretion assays revealed the occurrence of pyroptosis following treatment. Specifically, a 1-h treatment with caerin 1.1/1.9 induced pyroptosis in HeLa, A549, and Huh-7 cells, characterised by cell swelling, membrane bubbling, and the release of IL-18 and LDH. Western blotting confirmed the upregulat</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Caerin 1.1 and 1.9 peptides induce acute caspase 3/GSDME-mediated pyroptosis in epithelial cancer cells.</pubmed_title><pmcid>PMC12008296</pmcid><funding_grant_id>31971355</funding_grant_id><funding_grant_id>2016A020213001</funding_grant_id><funding_grant_id>2019A008</funding_grant_id><pubmed_authors>Fu Q</pubmed_authors><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Ni G</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors><pubmed_authors>Mo R</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Fu J</pubmed_authors><pubmed_authors>Tang S</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Song X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Caerin 1.1 and 1.9 peptides induce acute caspase 3/GSDME-mediated pyroptosis in epithelial cancer cells.</name><description>Caerin peptides exhibit a dual role in cancer treatment by directly killing cancer cells and modulating the tumour microenvironment to enhance anti-tumour immunity. This study investigates the mechanisms underlying caerin 1.1/1.9-induced acute cell death in epithelial cancer cells and explores their therapeutic potential. HeLa, A549, and Huh-7 cancer cell lines were treated with caerin 1.1/1.9 peptides. Morphological observations, flow cytometry, lactate dehydrogenase (LDH) release, and IL-18 secretion assays revealed the occurrence of pyroptosis following treatment. Specifically, a 1-h treatment with caerin 1.1/1.9 induced pyroptosis in HeLa, A549, and Huh-7 cells, characterised by cell swelling, membrane bubbling, and the release of IL-18 and LDH. Western blotting confirmed the upregulat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-06-28T03:05:31.876Z</modification><creation>2025-06-28T03:05:31.876Z</creation></dates><accession>S-EPMC12008296</accession><cross_references><pubmed>40251208</pubmed><doi>10.1038/s41598-025-96438-0</doi></cross_references></HashMap>